| Lesa Kagan, AUD, CCC-A | |
|
1360 Upper Hembree Rd, Suite 201, Roswell, GA 30076-1146 | |
| (770) 475-3361 | |
| (770) 664-4431 |
| Full Name | Lesa Kagan |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 18 Years |
| Location | 1360 Upper Hembree Rd, Roswell, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326251588 | NPI | - | NPPES |
| 1371 | Other | GA | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 1371 (Georgia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Georgia Surgical Professional Services Llc | 3375774011 | 47 |
News Archive
In a perspective article recently published in the journal Science, Hyeryun Choe and Michael Farzan from the Scripps Research Institute, USA, have described the early-stage evolution of SARS-CoV-2 in humans. They have provided a detailed overview of how early mutations in SARS-CoV-2 spike protein facilitate its adaptation in human systems.
PharmAbcine, a specialized biotech company focused on the development of fully-human monoclonal antibodies for the treatment of cancer and inflammatory diseases, announced that is has received $6 million USD in a Series A financing. OrbiMed's Caduceus Asia Partners and Novartis Korea Venture Fund co-led the round, with additional participation from an international syndicate including Green Cross, Tong Yang and Saehan Venture Fund.
A rabbit virus currently being developed for cancer therapy can be paired with one of several existing drugs to deliver a more potent punch to a deadly type of brain tumor cell, researchers have found.
A team of scientists describe the safety and response to REGEN-COV® for COVID-19 patients with immunodeficiency-associated antibody disorders.
› Verified 1 days ago
| Provider Name | Georgia Surgical Professional Services Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1801224506 PECOS PAC ID: 3375774011 Enrollment ID: O20140324000595 |
News Archive
In a perspective article recently published in the journal Science, Hyeryun Choe and Michael Farzan from the Scripps Research Institute, USA, have described the early-stage evolution of SARS-CoV-2 in humans. They have provided a detailed overview of how early mutations in SARS-CoV-2 spike protein facilitate its adaptation in human systems.
PharmAbcine, a specialized biotech company focused on the development of fully-human monoclonal antibodies for the treatment of cancer and inflammatory diseases, announced that is has received $6 million USD in a Series A financing. OrbiMed's Caduceus Asia Partners and Novartis Korea Venture Fund co-led the round, with additional participation from an international syndicate including Green Cross, Tong Yang and Saehan Venture Fund.
A rabbit virus currently being developed for cancer therapy can be paired with one of several existing drugs to deliver a more potent punch to a deadly type of brain tumor cell, researchers have found.
A team of scientists describe the safety and response to REGEN-COV® for COVID-19 patients with immunodeficiency-associated antibody disorders.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lesa Kagan, AUD, CCC-A Po Box 933087, Atlanta, GA 31193-3087 Ph: (770) 475-3361 | Lesa Kagan, AUD, CCC-A 1360 Upper Hembree Rd, Suite 201, Roswell, GA 30076-1146 Ph: (770) 475-3361 |
News Archive
In a perspective article recently published in the journal Science, Hyeryun Choe and Michael Farzan from the Scripps Research Institute, USA, have described the early-stage evolution of SARS-CoV-2 in humans. They have provided a detailed overview of how early mutations in SARS-CoV-2 spike protein facilitate its adaptation in human systems.
PharmAbcine, a specialized biotech company focused on the development of fully-human monoclonal antibodies for the treatment of cancer and inflammatory diseases, announced that is has received $6 million USD in a Series A financing. OrbiMed's Caduceus Asia Partners and Novartis Korea Venture Fund co-led the round, with additional participation from an international syndicate including Green Cross, Tong Yang and Saehan Venture Fund.
A rabbit virus currently being developed for cancer therapy can be paired with one of several existing drugs to deliver a more potent punch to a deadly type of brain tumor cell, researchers have found.
A team of scientists describe the safety and response to REGEN-COV® for COVID-19 patients with immunodeficiency-associated antibody disorders.
› Verified 1 days ago
Audiological Consultants Of Atlanta, Inc. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 875 Mansell Rd, Suite B2, Roswell, GA 30076 Phone: 678-461-6366 | |
Mrs. Mary Allen Mazeall, M.A. CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 8890 Club River Dr, Roswell, GA 30076 Phone: 770-518-9224 | |
Mrs. Julie Ann St. Vrain, M.A. CCC-A Audiologist Medicare: Medicare Enrolled Practice Location: 10800 Alpharetta Hwy, #122, Roswell, GA 30076 Phone: 770-992-5353 Fax: 770-998-4974 | |
Mrs. Susan Beth Fages, LIC-A Audiologist Medicare: Medicare Enrolled Practice Location: 2500 Hospital Blvd, Suite 450, Roswell, GA 30076 Phone: 770-343-8675 Fax: 770-343-8126 | |
Connect Hearing, Inc. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 10800 Alpharetta Hwy, Ste 198, Roswell, GA 30076 Phone: 770-992-5353 Fax: 770-998-4974 | |
Mr. Jason M Feld, M.C.D., CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 580 E Crossville Rd, Ste 340, Roswell, GA 30075 Phone: 678-352-1940 |